
In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219
INDICATIONS
Local disinfectant treatment of minor superficial wounds, abrasions, first degree burns, bedsores with involvement limited to the epidermis.
ACTIVE INGREDIENTS
100 ml contain: - Eosin: 2.0 g - Chloroxylenol: 0.3 g - Propylene glycol: 30.0 g For the complete list of excipients, see section 6.1.
EXCIPIENTS
95° ethanol; sodium edetate; acetic acid; purified water.
CONTRAINDICATIONS AND SIDE EFFECTS
Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1.
DOSAGE
Dosage: Apply a few drops to the injured part 1-2 times a day. Do not exceed the recommended doses. Method of administration: Apply the skin solution to the injured part and cover, if necessary, with an appropriate dry sterile bandage.
CONSERVATION
This medicinal product does not require any special storage conditions. Keep the bottle tightly closed, away from heat sources.
WARNINGS
The product is for external use only and should not be used for prolonged treatments. The use, especially prolonged, of products for topical use can give rise to sensitization phenomena, in which case it is necessary to interrupt the treatment and evaluate the need for suitable therapy. Accidental ingestion or inhalation of some disinfectants can have serious, sometimes fatal, consequences. Avoid contact with eyes. The medicine leaves stains on clothing that are difficult to remove. The container of this medicine is made of latex rubber. May cause serious allergic reactions.
INTERACTIONS
Avoid the simultaneous use of other antiseptics and detergents.
SIDE EFFECTS
In some cases, intolerance (burning or irritation) may occur, however without consequences and which does not require modification of the treatment. For repeated application or following occlusive dressing, eczematous skin reactions may occur. The solution can give rise to photosensitization phenomena. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.
OVERDOSE
Based on experimental studies conducted on animals, presumably not even the ingestion of 600 ml (twelve 50 ml bottles) would have any significant toxic effects. However, in the event of accidental ingestion of the preparation, as a specific antidote is not known, perform gastric lavage as an immediate intervention; if a certain period of time has passed, administer activated charcoal.
PREGNANCY AND BREASTFEEDING
Pregnancy: Eosin, chloroxylenol and propylene glycol are not expected to cause any effects during pregnancy, as systemic exposure to eosin, chloroxylenol and propylene glycol is negligible. Neomercurochrome can be used during pregnancy.
EFFECTS ON DRIVING ABILITY
Not applicable.








